Last quarter (Q3 2025), Aprea Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Aprea Therapeutics's net income was $-2.97M. See Aprea Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Total Revenue	$ 1.50M	$ 583.23K	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -7.86M	$ 576.18K	$ -16.40M	$ -271.68K	$ -229.61K
Operating Expenses	$ 6.46M	$ 16.05M	$ 96.99M	$ 37.17M	$ 52.81M
Depreciation and Amortization	$ 22.32K	$ 7.05K	$ 4.40K	$ 271.68K	$ 229.61K
EBITDA	$ -14.30M	$ -14.28M	$ -37.37M	$ -36.86M	$ -53.25M
Operating Income	$ -14.32M	$ -15.47M	$ -113.39M	$ -37.45M	$ -52.81M
Other Income/Expenses	$ 1.36M	$ 1.19M	$ 730.20K	$ 319.05K	$ -667.60K
Pretax Income	$ -12.96M	$ -14.29M	$ -112.66M	$ -37.13M	$ -53.48M
Net Income	$ -12.96M	$ -14.29M	$ -112.66M	$ -36.54M	$ -53.92M
Per Share Metrics
Basic EPS	$ -2.35	$ -3.95	$ -1.36K	$ -34.88	$ -50.61
Diluted EPS	$ -2.35	$ -3.95	$ -1.36K	$ -34.88	$ -50.61
Weighted Average Shares Outstanding	5.51M	3.62M	82.85K	1.06M	1.06M
Weighted Average Shares Outstanding (Diluted)	5.51M	3.62M	82.85K	1.06M	1.06M

Currency in USD

Aprea Therapeutics Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing